GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

OpenAI has unveiled GPT‑Rosalind, a new AI model focused on life sciences research. Named after Rosalind Franklin, the model ...

Trusted Answer Search is a new offering from Oracle that prioritizes control, auditability, and predictable outcomes over ...

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.

Explore Perplexity AI’s features, pricing, models, and tools. Learn how this answer engine blends real-time search with AI to ...

Tempo's Zones Heighten Privacy Scrutiny Across Crypto Networks. Tempo is rolling out a new feature called Zones, a ...

A new partnership between NanoCo and Vercel is tackling one of the most under-discussed bottlenecks in artificial intelligence: trust. As AI agents gain access to increasingly sensitive systems like ...

For companies, this creates both urgency and opportunity: organisations that adopt AI will have better audit defences, faster ...

A sweeping international law-enforcement campaign has disrupted one of the cybercrime market’s most accessible attack models, ...

A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...